4.7 Article

A nanocarrier based on a genetically engineered protein cage to deliver doxorubicin to human hepatocellular carcinoma cells

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

Acid-degradable polymers for drug delivery: a decade of innovation

Sandra Binauld et al.

CHEMICAL COMMUNICATIONS (2013)

Review Pharmacology & Pharmacy

Virus-based nanocarriers for drug delivery

Yujie Ma et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

Article Biochemical Research Methods

Development of Human Hepatocellular Carcinoma Cell-Targeted Protein Cages

Riki Toita et al.

BIOCONJUGATE CHEMISTRY (2012)

Article Nanoscience & Nanotechnology

Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages

Masaharu Murata et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)

Review Chemistry, Multidisciplinary

Impact of albumin on drug delivery - New applications on the horizon

Bakheet Elsadek et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Article Chemistry, Multidisciplinary

Gene Carrier Showing All-or-None Response to Cancer Cell Signaling

Riki Toita et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)

Review Pharmacology & Pharmacy

Anthracyclines and ellipticines as DNA-damaging anticancer drugs: Recent advances

Rene Kizek et al.

PHARMACOLOGY & THERAPEUTICS (2012)

Review Pharmacology & Pharmacy

Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers

Younsoo Bae et al.

ADVANCED DRUG DELIVERY REVIEWS (2009)

Article Biochemistry & Molecular Biology

A novel protease activity assay using a protease-responsive chaperone protein

Kentaro Sao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)

Article Biochemistry & Molecular Biology

Molecular design of protein-based nanocapsules for stimulus-responsive characteristics

Kentaro Sao et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2009)

Article Chemistry, Multidisciplinary

Photosensitizer efficiency in genetically modified protein cage architectures

Zachary Varpness et al.

CHEMICAL COMMUNICATIONS (2009)

Review Pharmacology & Pharmacy

Active targeting schemes for nanoparticle systems in cancer therapeutics

James D. Byrne et al.

ADVANCED DRUG DELIVERY REVIEWS (2008)

Article Oncology

Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery

Albert Lo et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Article Chemistry, Multidisciplinary

Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture

ML Flenniken et al.

CHEMICAL COMMUNICATIONS (2005)